Naive group | Treated patients | STI patients | |
---|---|---|---|
Number | 10 | 20 | 15 |
Genders | |||
Males | 5 | 8 | 8 |
Females | 5 | 12 | 6 |
Transsexuals | 1 | ||
Mean years old | 42 | 42 | 43 |
Geographic origin | |||
Europeans | 5 | 12 | 12 |
Other/Unknown | 5 | 8 | 3 |
Mean range follow up | |||
Yearsa | 4 (range 1 – 11) a | 7.5 (range 1 – 15)a | 6 (range 2 – 7) a |
CD4+ count | |||
cells × 106/l | Median 391 (range 109–805) | Median 338 (range 1 – 790) | Median 717 (range 216 – 1356) |
<200 cells × 106/l (Number) b | 1 | 6 | 0 |
Plasma HIV-RNA | |||
Log10 copies/ml | Median 4.8 (range 2.7 – 5.4) | Median 4.4 (range 1.7 – 5.9) | Median 3.2 (range 1.7 – 4.7) c |
<50 copies/ml (Number)b | 0 | 5 | 3 |
HIV1-DNA | |||
Log10 copies/106 CD4 cells | Median 3.0 (range 2.6 – 3.7) | Median 3.3 (range 2.2 – 4.6) | Median 2.9 (range 2.1 – 4.0) |
<5 copies/PCR (Number) b | 6 | 12 | 5 |